The first diagnostic test available for the confirmation of chronic
sinusitis (CS) disease has been made available by Accentia
Biopharmaceuticals, which will assist in the identification of a
problem that affects an estimated 31 million...
A toxicology-on-a-chip tool, which can analyse drug candidates for
toxicity before they advance to pre-clinical stages, has taken one
step further towards commercialisation as the technology promises
to aid laboratory researchers...
EU ministers yesterday agreed on a compromise version of the
controversial new chemicals law, REACH, however environment groups
have condemned the latest changes as a further watering down of the
law in favour of industry.
SciGen are to establish a manufacturing facility in China in a
response to the growing demand for the Hepatitis B (HBV) vaccine
and insulin, which has reached epidemic proportions with 2 billion
people having become infected with...
SRA International has received a $15 million outsourcing contract
from the National Institutes of Health (NIH) to provide enterprise
messaging and IT infrastructure support services over the next 6
years.
Drug production company Patheon has released its fourth-quarter
results, which has revealed that profit has jumped 180 per cent
despite a recent production halt at a Puerto Rican subsidiary. This
bodes well for the recent manufacturing...
GlaxoSmithKline (GSK) has positioned itself to dominate the US flu
vaccine market after it completed the acquisition of Canadian
vaccine company ID Biomedical for $1.7 billion (€1.15 billion) last
week.
US drug company, Eli Lilly, offered a more encouraging outlook than
was expected forecasting an earnings growth of up to 12 per cent, a
stark contrast to its struggling competitors, who also face generic
competition, drug safety and...
Shanghai-based biotech company WuXi PharmaTech has grown more than
100 times in the last 5 years after operating successfully in
China's infant biotech industry by providing variety of outsourcing
services in drug R&D.
Ventiv health reported a strong performance across all its business
units in the third quarter, with total revenues increasing by 44
per cent to $128.4 million (€107.6 million) compared to the third
quarter of 2004.
Thermo Electron Corporation, have added to its crystallisation
range with the new compact, entry-level, TableStore, which enhances
protein structure and drug discovery investigations by offering
optical clarity and automated storage...
Solexa has announced the introduction of its DNA sequencing,
expression profiling and micro-RNA analysis platform designed to
generate over a billion bases of sequence per run, making it ideal
for plans to sequence the entire human...
A new therapy for Parkinson's disease involving brain implants has
been developed by US scientists, who believe this new treatment is
a viable alternative to drugs currently used to treat this chronic
irreversible brain condition.
CuraGen and TopoTarget have announced preliminary data suggesting
its small molecule candidate may have potential anti-tumour
activity against haematologic cancer.
US drug company, Eli Lilly, offered a more encouraging outlook than
was expected forecasting an earnings growth of up to 12 per cent, a
stark contrast to its struggling competitors, who also face generic
competition, drug safety and...
The world's first transdermal patch for the treatment of
Alzheimer's disease (AD) will offer patients an improved treatment
delivery choice and could lead to more patients taking their
medication.
Roche has responded to recent criticism that it was protecting its
avian-flu formula too closely by identifying 12 prospective
partners to increase the global production of Tamiflu.
UK drug development company SkyePharma, which put itself up for
sale last month, has said that several new bidders have expressed
interest in buying some of its assets as well as acquiring the
entire company for cash.
Biovest International used the Cancer Research Institute's recent
meeting to debut its newest cell culture instrument, the
AutovaxID-C, which represents an advance in personalised medicine,
reducing the possibility of cross contamination,...
SR Pharma, specializing in RNAi therapeutics, will be the first
company to use the new UK National Biomanufacturing Centre (NBC),
operated by contract manufacturing organization (CMO) Eden
Biodesign, when it opens on schedule early...
Contract research organisations (CROs) are responding to the
looming threat of competition from India and China by moving
outside their traditional role of simply providing contract
services to drug companies.
UK's MedPharm has received a Department of Trade and Industry (DTI)
grant for Research and Development to produce its new spray
treatment for eczema, expected to be available in the US by 2009.
Covalent Group has improved its financial position on last year,
reporting a net revenue increase of 45 per cent for the third
quarter of 2005 with sales of $2.7 million, (€2.3 million) compared
to $1.9 million one year ago.
Pharmaceutical companies and manufacturers are increasingly moving
to adopt software services that prevent revenue leakage and
regulatory compliance exposure.
Generex Biotechnology announced its Oral-lyn, the first
non-injectable form of recombinant human insulin available for
commercial distribution anywhere in the world is being launched in
Ecuador to soon become available through physician...
Innovata has entered into a second agreement in which the
development of a combination asthma therapy could generate in
excess of £25 million (€37 million) in milestones and development
funding.
CombiMatrix Molecular Diagnostics (CMD) are to collaborate with the
University Of California (UCLA), on a gene-based melanoma
laboratory test, which if successful, could result in the
development of a clinical molecular test that...
Samson Medical Technologies has signed a co-marketing agreement
with Baxa for its novel packaging system designed to improve
patient safety by reducing the risk of medication errors in
prescription drug compounding.
Clontech has announced a new addition to its TALON chemistry range,
which uses magnetic bead technology to separate microscale
quantities of protein when placed on a magnetic separator.
According to a new report, 2006 will be a crunch year for companies
that have expiring product patents looming. With generics
increasingly penetrating the market, this has thrown into doubt the
growth of this industry in the foreseeable...
GE Healthcare has announced the availability of its single-use spin
column designed for purification of histidine-tagged proteins using
a standard microcentrifuge. It saves researchers time as it
achieves direct protein purification...
Phoqus has announced it has commenced Phase I of a clinical study
researching its experimental treatment, which could become the
first Circadian endocrine treatment for adrenal insufficiency.
Filtration system Pall Corporation reported its first quarter
earnings which revealed earnings rose by 16 per cent, propelled by
growth in its industrial and biopharmaceuticals segments.
Invitrogen has created three new business divisions in a move to
strengthen its position in the growing biotechnology industry and
drive growth through improving links between its product
development cycle and customer base.
According to a new report, the demand for worldwide drug packaging
is expected to reach new heights, predicting growth of 5.3 per cent
annually to $24.3 billion (€20 7 billion) in 2009, driven by aging
demographic patterns increasing...
As low-cost contract manufacturing organisations (CMO) in Asia are
becoming more attractive to drug companies, Western CMOs are having
to develop new business strategies in order to compete.
A new algorithm, which automatically selects molecule images for
crystallisation in Silico studies, is set to advance laboratory
studies by increasing the speed and power of methods for
determining biological structures at high resolution,...
Accelovance has broadened its presence in China and expanded its
capacity for conducting Phase I-IV clinical trials for Western
pharmaceutical and biotech firms seeking to enter the Chinese
market, by opening a new office in Shanghai.
After a two-year tug-of-war, the World Trade Organization (WTO) has
solidified a landmark agreement to allow poor nations to import
generic versions of patented drugs to treat serious diseases or
epidemics.
Domantis has announced an alliance with pharma giants Bristol-Myers
Squibb to develop human Domain Antibody (dAb) products, a novel
approach to address therapeutic targets involved in T-cell
co-stimulation.
The question as to why some cancers resist drugs could be answered
by the discovery of new mechanisms, which delve deeper into how
cancer cells evolve to become resistant to various chemotherapy
drugs.
A dairy based vaccine could soon be on the horizon after
researchers took a giant step in the development of a series of
effective cancer-fighting vaccines that appear to be able to stop
and reverse cancer growth.
Stratagene announces a molecular diagnostics agreement, which aims
to focus on the growing molecular diagnostics market for infectious
diseases, currently worth $6.5 billion (€5.5 billion), expanding to
$12 billion by 2010 driven...
Researchers believe that they have identified a drug target
molecule that could be used to treat mental impairment in people
with Down's syndrome paving the way for a treatment that could
improve the quality of life for sufferers.
Aegate will launch a software solution to combat one of the
pharmaceutical industry's biggest and growing patient safety issues
- counterfeit drugs - in the UK, US and Belgium in 2006 following
the recent success of its UK pilot...
Grunenthal has developed a novel method of delivering drugs to
children in the form of a drinking straw, which is set to provide a
solution to administering treatment to patients who cannot tolerate
unpleasant tasting drugs.
Baxa Corporation launches its medication validation system that
validates narcotic returns and identifies counterfeit medications.
The system also offers validation of medication to ensure the type
and strength of high-risk medications.
BASF has announced that it is to raise prices of its pharmaceutical
excipients in a move that represents the wider market that has seen
big cost increases for raw materials, energy and transportation
that has affected all excipient...
Clinical research organisation, Covalent Group, has agreed with
Emergent BioSolutions to develop immune globulins for treatment
exposure of anthrax infection, signifying another step in the
worldwide drive to bring an effective treatment...
Clinical trials service provider, The Specials Clinical
Manufacturing, has announced the recent installation of Isopak's
In-Cap machine, an automatic bench machine that is currently the
smallest automatic filling machine in the...
